Abstract:Objective:To evaluate the efficacy and security of preoperative brachyther-apy combinded concurrent chemotherapy ( preoperative brachy-chemothepapy ) in the compre-hensive treatment for patients with FIGO stage ⅠB2 andⅡA2 cervical cancer. Methods:Total of 82 patients with FIGO stage ⅠB2 andⅡA2 cervical cancer were enrolled retrospectively treated in the department of Gynaecology of Drum Tower Hospital affiliated to Medical College of Nanjing University from June 2010 to May 2015 . According to the different preoperative regi-mens,they were categorized into three groups,including directly surgical group ( Group A,27 cases) ,neoadjuvant chemotherapy group ( Group B,41 cases) ,and brachy-chemotherapy group ( Group C,14 cases) . Radical hysterectomy was performed following the later two regimens. To compare three groups of postoperative hospital stay, average intraoperative blood loss, average surgical time,clinical pathological remission rate,incidence of complications and recent survive time. Results:Postoperative hospital stay was significantly more in group B than group A. Intra-operative blood loss was significantly more in group B than in group C. These difference were statistically significant (P<0. 05). Vascular invasion rate,deep muscle invasion rate and lymph node positive rate in group C were lower than in group A and B. All these difference were statis-tically significant (P<0. 05),and no statistically significant difference were noted in latter two groups (P>0. 05),and three groups had no significant difference in nerve invasion rate (P>0. 05 ) . The preoperative therapeutic effective rate of 85 . 7% in group C was much higher than 36 . 4% in group B with a statistically significant difference ( P<0 . 05 ) . The occurrence rate of sur-gery-related complications and nerve invasion rate had no statistically significant difference a-mong three groups. Median survival time and 3-year survival rate in group A,B and C were 41. 2 months(95%CI:33. 8 ~48. 5 months) and 63. 9%,33. 8 months(95%CI:28. 9 ~38. 7 months)and 53. 1%,48. 1 months(95%CI:37. 5 ~58. 7 months)and 68. 2% respectively, where there were no statistically significant difference among three groups ( P>0 . 05 ) . Lymph node metastasis was a independent risk factor of decreasing survival time ( P<0 . 05 ) . Conclu-sions:For no-significantly increasing the occurrence rate of surgery-related complications,surgi-cal time,intraoperative blood loss,preoperative brachytherapy combinded concurrent chemother-apy is a safe and effective regimen for patients with stage ⅠB2 andⅡA2 cervical cancer.

Preoperative Transarterial Chemoembolization for Cervical Cancer:Analysis of Efficacy

Effect of transcatheter arterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor in cervical squamous cell carcinoma

Preoperative Intraarterial Chemotherapy for Cervical Carcinoma in Stage Ⅱ b

Evaluation of the Curative Effect of Transcatheter Arterial Chemoembolization Via Hepatic Artery Combined with Percutaneous Ethanol Injection for the Treatment of Primary Hepatocellular Carcinoma

Preoperative Renal Artery Infusion Chemoembolization for Intermediate- and Advanced-Stage Renal Carcinoma

Intra-arterial Chemotherapy Followed by Radical Hysterectomy for Massive Cervical Cancer in stage ⅠB-ⅡB

Preoperative Combined with Postoperative Chemoembolization Can Improve Survival in Patients with Hepatocellular Carcinoma: A Single-center Study

Application of Neoadjuvant Chemotherapy in Cervical Carcinoma

Short-term efficacy and security of preoperative afterloading brachytherapy combinded concurrent chemotherapy for patients with FIGO stage ⅠB2 and Ⅱ A2 cervical cancer

Effect of Perioperative Comprehensive Nursing Intervention on Transcatheter Arterial Chemoembolization in Patients with Primary Hepatic Carcinoma

[Efficacy Assessment of Preoperative Radiochemotherapy and Analysis of Associated Factors in Rectal Cancer].

Application of preoperative embolization combined with subclavian artery balloon occlusion in surgical resection of shoulder girdle tumor with rich blood supply

[The Impact to Operation Safety of Preoperative Renal Artery Embolization for Management of Diameter≥10 Cm Renal Cell Carcinoma].

Prospective Randomized Controlled Study on Multiple Preoperative Treatments in Stage Ib2 to Iia Cervical Cancer.

Discussing the safety and effectiveness of transcatheter arterial embolization combined with intravenous chemotherapy in treating locally advanced breast cancer

Pathological and clinical effects of preoperative arterial infusion chemotherapy on the breast cancers

Effect of preoperative adjuvant transcatheter hepatic arterial chemoembolization on prognosis of resectable huge hepatocellular carcinoma

Neoadjuvant chemotherapy combined with radical surgery for stage IB2/IIA2 cervical squamous cell carcinoma: a prospective, randomized controlled study of 35 patients

Meta-analysis of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer

Application of Bronchial Arterial Chemoembolization for Treating Advanced Lung Cancer

[Preoperative Arterial Infusion Chemotherapy of Colorectal Carcinoma Pathological and Clinical Effects].